We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Scaffold for Bone Growth that Can Treat Bone Loss

By HospiMedica staff writers
Posted on 23 Jun 2003
A biodegradable scaffold that eventually dissolves can grow new tissue and offer a potential treatment for bone loss in cases such as trauma or spinal fusions. More...
The research was reported in the June 15, 2003, issue of the Journal of Biomedical Materials Research.

Although bone can replace itself, in some traumatic cases there is too much damage for the bone to heal on its own. Bone grafting is a common solution but often the patient does not have enough bone to move from one place to another. So researchers seeking a solution experimented with polymers and natural bone tissue to find a new method of bone regeneration. They eventually developed a scaffold with polymers similar to those found in dissolving structures and with a structure similar to a large-pored dishwashing sponge.

After seeding the scaffold with bone marrow cells, the scaffold was implanted in the damaged femur bones of rabbits. Within six weeks, the animals could walk on the legs containing the scaffold. Within eight weeks, the bone marrow cells had developed into bone throughout the scaffold, which gradually dissolved. The technique does not require the use of bone growth factors. The researchers plan now to study the scaffolds in larger animals, with the goal of creating a human treatment that would speed the early healing of trauma.

"It's not only better for the patient, but it gets the patient out of the bed and out of the hospital soon, so there's less cost to the healthcare system,” said co-investigator John Davies, professor of chemical engineering and applied chemistry at the Institute for Biomaterials and Biomedical Engineering at the University of Toronto (IBBME, Canada).




Related Links:
Univ. of Toronto

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Head Rest
Medifa 61114_3
MRI System
nanoScan MRI 3T/7T
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.